This inventor holds 1 USPTO granted patent. Top assignee: Health Research, Inc.. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Kenneth W. Gross: Innovator in Transgenic Mouse Research
Introduction
Kenneth W. Gross is a notable inventor based in East Concord, NY (US). He has made significant contributions to the field of genetic research, particularly through his work on transgenic mice. His innovative approach has opened new avenues for understanding diseases involving dopaminergic dysfunction.
Latest Patents
Kenneth W. Gross holds a patent for a transgenic mouse model designed to study diseases related to dopaminergic dysfunction. The patent, titled "Transgenic mouse as model for diseases involving dopaminergic dysfunction," describes a transgenic mouse exhibiting a circling phenotype due to insertional mutagenesis. This mutation results from the introduction of genetic material into the mouse's genome at an embryonic stage, which alters an endogenous genetic locus affecting motor function. The transgenic mouse line, designated TgX15, has been identified as a valuable resource for investigating the molecular genetic mechanisms that influence brain function and behavior. Furthermore, these mice may serve as a platform for evaluating new therapeutic agents for disorders such as Parkinsonism and schizophrenia. Kenneth W. Gross has 1 patent to his name.
Career Highlights
Kenneth W. Gross is associated with Health Research, Inc., where he continues to advance his research in genetic engineering and its applications in medical science. His work has garnered attention for its potential impact on understanding and treating neurological disorders.
Collaborations
Throughout his career, Kenneth has collaborated with esteemed colleagues, including Stanley D. Glick and John J. Mullins. These partnerships have contributed to the depth and breadth of his research endeavors.
Conclusion
Kenneth W. Gross is a pioneering inventor whose work with transgenic mice has the potential to transform our understanding of dopaminergic dysfunction and its related disorders. His contributions to genetic research are invaluable and continue to inspire future innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile